Sign In to Follow Application
View All Documents & Correspondence

Pd 1 Agonist Antibodies And Methods Of Treating Autoimmune Diseases With A Pd 1 Agonist Antibody

Abstract: The present disclosure relates to novel PD 1 agonist antibodies and methods and uses of anti human PD 1 agonist antibodies for the treatment of autoinflammatory and/or autoimmune diseases. Also provided are doses and dosing regimens for the methods and uses of anti human PD 1 agonist antibodies for the treatment of autoinflammatory and/or autoimmune diseases such as RA.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
10 March 2025
Publication Number
13/2025
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application

Applicants

ELI LILLY AND COMPANY
Lilly Corporate Center Indianapolis Indiana 46285

Inventors

1. FENG Yiqing
c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis Indiana 46206 6288
2. KILEY Christina Marie
c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis Indiana 46206 6288
3. NIRULA Ajay
c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis Indiana 46206 6288
4. TUTTLE Jay Lawrence
c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis Indiana 46206 6288
5. WANG Evan Bo
c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis Indiana 46206 6288
6. YACHI Pia Pauliina
c/o ELI LILLY AND COMPANY P.O. Box 6288 Indianapolis Indiana 46206 6288

Specification

Documents